top of page
Dr. Craig Lockhart on the BackTable Tumor Board Podcast

Dr. Craig Lockhart

Medical Oncologist

3 Podcasts on BackTable

Dr. A. Craig Lockhart is a medical oncologist at the Medical University of South Carolina.

Learn from the experiences and expertise of Dr. Craig Lockhart and other leading voices in your specialty on the BackTable app.

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 59  •  12 May 2026

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.

More from Dr. Craig Lockhart

Loading recent podcasts…

About

Dr. Albert Lockhart has been caring for patients with gastrointestinal cancers for over 20 years. His particular areas of expertise and the focus of his research is in treating gastric and esophageal cancers. He also sees patients with colorectal and pancreatic cancers.

Dr. Lockhart's research aims to bring new therapies to cancer patients by conducting clinical research studies involving new treatment approaches and personalized medicine.

At MUSC Hollings Cancer Center, Dr. Lockhart is the Director of the Division of Hematology \& Oncology and Associate Director for Clinical Science. Prior to joining MUSC, Dr. Lockhart was on the faculty and in leadership roles at the University of Miami, Miller School of Medicine, Washington University in St. Louis/Siteman Cancer Center, and at Vanderbilt University/Vanderbilt-Ingram Cancer Center.

Dr. Lockhart graduated from the University of Texas Southwestern Medical School at Dallas in 1993. He completed residency training at Barnes Hospital at Washington University, fellowship training in hematology/oncology at Duke University, and a fellowship in drug development at GlaxoSmithKline in the North Carolina Research Triangle Park. He also earned a master's of health science (MHS) in clinical trials at Duke University. He completed his undergraduate degree, a bachelor's degree in biology, from Rice University.

Visit MUSC Health to learn more about Dr. Craig Lockhart.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page